Clinical trials
Not yet recruiting Observational Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 12 |
| 2025 | 12 |
| 2026 | 29 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anhui Medical University | 3 |
| AstraZeneca | 3 |
| Power Life Sciences Inc. | 3 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 3 |
| IRCCS San Raffaele | 2 |
| Peking University First Hospital | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| Ain Shams University | 1 |
| Alberta Health services | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 54 |
| Disease | 6 |
| Adenocarcinoma | 2 |
| Kidney Neoplasms | 2 |
| Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Aortic Diseases | 1 |
| Carcinoma, Hepatocellular | 1 |
| Erectile Dysfunction | 1 |
| Liver Neoplasms | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.